Vivos Therapeutics Announces Filing of Registration Statement for Proposed Initial Public Offering
October 09, 2020 16:55 ET
|
Vivos Therapeutics Inc.
HIGHLANDS RANCH, Colorado, Oct. 09, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- Vivos Therapeutics, Inc. (“Vivos”), a medical technology company that offers novel and proprietary alternatives for...
RespireRx Pharmaceuticals Inc. Announces Extension to Long-Term Employment Contract with Tim Jones as President and Chief Executive Officer
August 03, 2020 15:11 ET
|
RespireRX Pharmaceuticals Inc.
Glen Rock, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTC: RSPI) (“RespireRx” or the “Company”), is pleased to announce that today, Mr. Tim Jones and RespireRx have...
Philips data-driven Mask Selector delivers unique patient and business benefits
July 09, 2020 09:30 ET
|
Royal Philips
July 9, 2020 First and only clinically-validated mask selection, sizing and fitting solution that helps providers fit patients with the right mask from the start [3]3D facial scanning...
InvestorBrandNetwork (IBN) Coverage Initiated for Vivos Therapeutics Inc.
June 11, 2020 08:30 ET
|
Vivos Therapeutics Inc.
NEW YORK, June 11, 2020 (GLOBE NEWSWIRE) -- via NetworkWire – Vivos Therapeutics Inc., a company focused on addressing the root causes of mild to moderate sleep apnea, today announces it has...
REMSleep Holdings Eliminates Convertible Toxic Debt from its Balance Sheet
April 06, 2020 06:00 ET
|
REMSleep Holdings, Inc.
TAMPA, FL, April 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – REMSleep Holdings, Inc. (OTC PINK: RMSL) is happy to announce that it has eliminated convertible, toxic notes from its balance sheet....
Novel Oral Device a Breath of Fresh Air for Canadian Sleep Apnea Sufferers
March 03, 2020 08:41 ET
|
Oventus Medical Ltd
TORONTO, March 03, 2020 (GLOBE NEWSWIRE) -- Canadians living with obstructive sleep apnea (OSA) who are frustrated with cumbersome and uncomfortable CPAP machines can breathe easier thanks to an...
Oxygen Therapy Devices Market To Reach USD 4.92 Billion By 2026 | Reports and Data
February 26, 2020 16:00 ET
|
Reports and Data
New York, Feb. 26, 2020 (GLOBE NEWSWIRE) -- According to the current analysis of Reports and Data, the global Oxygen Therapy Devices market was valued at USD 2.54 billion in 2018 and is expected to...
REMSleep Holdings, Inc. Launches Official Web Site and Twitter Account
January 30, 2020 13:00 ET
|
REMSleep Holdings, Inc.
Tampa, FL, Jan. 30, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --REMSleep Holdings, Inc. (OTC: RMSL) (the “Company”) announced today that it has launched its official website Remsleep.com and has...
REMSleep Receives Production of the New Deltawave CPAP Interface
September 16, 2019 09:00 ET
|
REMSleep Holdings, Inc.
ORLANDO, FL, Sept. 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – REMSleep Holdings, Inc. (OTC PINK: RMSL) and its principals are pleased to announce the company has received Deltawave production...
REMSleep is Preparing to Introduce Deltawave to Market
August 12, 2019 09:00 ET
|
REMSleep Holdings, Inc.
ORLANDO, FL, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – REMSleep Holdings, Inc. (OTC PINK: RMSL) and its principals are pleased to announce the first production run of the new Deltawave is...